Skip to main content

Table 2 Demographic and hematologic characteristics of study and control cohort

From: A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia

 

N = 21

N = 55

P value

Age at diagnosis (mean [range])

1.2 (3.0–12.2)

8.5 (0.1–19.4)

0.181

Gender, male (N [%])

11 (52)

31 (56)

0.755

CNS status

N (%)

N (%)

 

CNS 1

11 (52)

31 (56)

0.355

CNS 2

6 (29)

17 (31)

 

CNS 3

1 (5)

6 (11)

 

Missing

2 (10)

6 (11)

 

FAB classification

N (%)

N (%)

 

M1

1 (5)

7 (13)

0.795

M2

4 (19)

5 (9)

 

M4

2 (10)

7 (13)

 

M5

9 (43)

21 (38)

 

M7

1 (5)

3 (5)

 

Missing

2 (10)

12 (22)